Simultaneous Pulmonary Embolism and Ischemic Stroke in a Patient with Cor Biloculare after Glenn Anastomosis
Keywords:Cor biloculare, Glenn anastomosis, thrombosis
Background: Cor biloculare, two-chambered heart due to the absence of atrial and ventricular septa, is a rare congenital heart anomaly. For Cor biloculare and other cardiac defects with single ventricle physiology, Glenn anastomosis has been developed as a palliative procedure. Thrombosis secondary to Glenn anastomosis in the patient with Cor biloculare could pose a serious threat to the survival, and has never been reported before.
Case report: We report the case of a 27-year-old patient, with past history of Glenn anastomosis that was performed 7 years ago for the palliation of Cor biloculare. She presented with pulmonary embolism and ischemic stroke simultaneously at 7 days after Cesarean section. Due to her critical status, systemic anticoagulation with low-molecular-weight heparin was started immediately, followed by lifelong warfarin therapy. Pulmonary embolism regressed and neurological symptoms were considerably diminished after the anticoagulation treatment.
Conclusion: This case illuminates the potential risk of thrombotic events in this patient cohort and demonstrates that anticoagulation therapy is an effective, secure, and appropriate for the management of this disease.
Bonnel AR. 2015. Thrombolytics for late superior caval vein thrombus in a patient with tricuspid atresia and single-lung Glenn anastomosis. Cardiol in Young 1:1-5.
Forbes TJ, Rosenthal GL, Jr RG, Ott DA, Feltes TF. 1997. Risk factors for life-threatening cavopulmonary thrombosis in patients undergoing bidirectional superior cavopulmonary shunt: an exploratory study. Am Heart J 134:865-71.
Gunta S, Kamath S. 2012. A case of pulmonary embolism and stroke in a 16-year-old girl. WMJ 111:58-60.
Iannoli ED, Eaton MP, Shapiro JR. 2005. Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis. Anesthes Analg 101:74-6, table of contents.
Jonas RA. 1994. Indications and timing for the bidirectional Glenn shunt versus the fenestrated Fontan circulation. J Thorac Cardiovasc Surg 108:522-4.
Kopf GS, Laks H, Stansel HC, Hellenbrand WE, Kleinman CS, Talner NS. 1990. Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts. J Thorac Cardiovasc Surg 100:670-1.
Koutlas TC, Harrison JK, Bashore TM, O'Laughlin MP, Tripp ME, Gaynor JW. 1996. Late conduit occlusion after modified Fontan procedure with classic Glenn shunt. Ann Thorac Surg 62:261-2.
Kozicka UA, Kowalski M, Hoffman P. 2015. Thrombosis within Glenn anastomosis. J Rare Cardiovasc Dis 2:89-91.
Liu M, Menzoian JO. 2015. A patient with multiple paradoxical emboli. J Vasc Surg 63:1085-7.
Odegard KC, Jr MG, Dinardo JA, et al. 2002. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure J Thorac Cardiovasc Surg 123:459-65.
Omar HR, Huang C, Miller JH, Mangar D, Kabemba A, Camporesi EM. 2013. Simultaneous pulmonary embolism and cerebrovascular stroke. Herz 38:884-6.
Oski JA, Canter CE, Spray TL, Kan JS, Cameron DE, Murphy AM. 1996. Embolic stroke after ligation of the pulmonary artery in patients with functional single ventricle. Am Heart J 132:836-40.
Pennington DG, Nouri S, Ho J, et al. 1981. Glenn shunt: long-term results and current role in congenital heart operations. Ann Thorac Surg 31:532-9.
Ravn HB, Hjortdal VE, Stenbog EV, et al. 2001. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85:61-5.
Temple WW, Bloor CM. 1981. Cor biloculare and associated malformations. Virchows Archiv 391:345-56.
Wang YB, Fu XH, Gu XS. 2014. Dextrocardia with cor biloculare in a 44 Year old woman. J Case Reports 4:245-8.
Wiszniewska M, Bytowska A. 2013. Ischemic stroke due to postpartum angiopathy complicated by pulmonary embolism with favorable outcome. Acta Clinica Croatica 52:267.
Yuan SM, Jing H. 2009. Palliative procedures for congenital heart defects. Archiv Cardiovas Dis 102:549-57.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).